Suppr超能文献

1982 - 1990年瑞氏综合征临床模式的变化

The changing clinical pattern of Reye's syndrome 1982-1990.

作者信息

Hardie R M, Newton L H, Bruce J C, Glasgow J F, Mowat A P, Stephenson J B, Hall S M

机构信息

PHLS Communicable Disease Surveillance Centre, London.

出版信息

Arch Dis Child. 1996 May;74(5):400-5. doi: 10.1136/adc.74.5.400.

Abstract

OBJECTIVE

To describe trends in the clinical pattern of Reye's syndrome in the British Isles between 1982 and 1990; and to determine the relation between any changes and the June 1986 warnings against the use of aspirin in children.

DESIGN

Development, and application to reported cases, of a scoring system designed such that patients showing the typical clinical and pathological features of 'classical' Reye's syndrome scored highly. The relations between 'Reye scores' and a number of explanatory variables were explored using multivariable analysis.

SETTING

British Isles.

SUBJECTS

445 cases fulfilling the Reye's syndrome case definition reported to the surveillance scheme between January 1982 and December 1990.

MAIN OUTCOME MEASURE

Individual 'Reye score'.

RESULTS

Cases with high scores were more likely to have occurred in the 4 1/2 year period before June 1986 compared with the subsequent period (p < 0.006). Numbers of cases in the low and intermediate score categories declined by about 50% after June 1986, whereas those in the high category fell by 79%. High scorers were more likely to have received aspirin (p < 0.0001) and were older than intermediate and low scorers (p < 0.008). No relation was identified between score and season of onset.

CONCLUSIONS

The decline in Reye's syndrome after the aspirin warnings cannot be explained entirely, as has been proposed, by improved diagnosis of 'Reye-like' inherited metabolic and other disorders: this would not account for the greater decline of the high scoring subgroup which also contained those cases most likely to resemble 'classical' Reye's syndrome and to have received aspirin. This study provides further evidence for the role of aspirin in a subset of cases meeting the standard diagnostic criteria for Reye's syndrome and supports the need to consider this disorder as a heterogeneous group of conditions including Reye-like inherited metabolic disorders.

摘要

目的

描述1982年至1990年间英伦诸岛瑞氏综合征临床模式的变化趋势;并确定这些变化与1986年6月发布的儿童禁用阿司匹林警告之间的关系。

设计

开发一种评分系统并将其应用于报告的病例,该评分系统的设计使得表现出“经典”瑞氏综合征典型临床和病理特征的患者得分较高。使用多变量分析探讨“瑞氏评分”与一些解释变量之间的关系。

地点

英伦诸岛。

研究对象

1982年1月至1990年12月期间向监测计划报告的445例符合瑞氏综合征病例定义的病例。

主要观察指标

个体“瑞氏评分”。

结果

与1986年6月之后的时期相比,高分病例在1986年6月之前的4.5年期间更有可能出现(p<0.006)。1986年6月之后,低分和中等分数类别的病例数下降了约50%,而高分类别中的病例数下降了79%。高分者更有可能服用过阿司匹林(p<0.0001),且年龄高于中等和低分者(p<0.008)。未发现评分与发病季节之间存在关联。

结论

阿司匹林警告发布后瑞氏综合征的下降不能完全如所提出的那样,通过对“类瑞氏”遗传性代谢和其他疾病的诊断改善来解释:这无法解释高分亚组更大幅度的下降,该亚组也包含那些最有可能类似“经典”瑞氏综合征且服用过阿司匹林的病例。本研究为阿司匹林在一部分符合瑞氏综合征标准诊断标准的病例中的作用提供了进一步证据,并支持将这种疾病视为包括类瑞氏遗传性代谢疾病在内的一组异质性病症的必要性。

相似文献

1
The changing clinical pattern of Reye's syndrome 1982-1990.
Arch Dis Child. 1996 May;74(5):400-5. doi: 10.1136/adc.74.5.400.
2
Trends in the incidence of Reye's syndrome and the use of aspirin.
Arch Dis Child. 1990 Aug;65(8):826-9. doi: 10.1136/adc.65.8.826.
3
Reye's syndrome.
Epidemiol Rev. 1989;11:249-53. doi: 10.1093/oxfordjournals.epirev.a036043.
4
Reye's syndrome in the United States from 1981 through 1997.
N Engl J Med. 1999 May 6;340(18):1377-82. doi: 10.1056/NEJM199905063401801.
6
Is aspirin a cause of Reye's syndrome? A case against.
Drug Saf. 2002;25(4):225-31. doi: 10.2165/00002018-200225040-00001.
7
Preadmission antipyretics in Reye's syndrome.
Arch Dis Child. 1988 Jul;63(7):857-66. doi: 10.1136/adc.63.7.857.
9
Investigation of metabolic disorders resembling Reye's syndrome.
Arch Dis Child. 1992 Oct;67(10):1313-7. doi: 10.1136/adc.67.10.1313.
10
Reye's and Reye's-like syndromes.
Cell Biochem Funct. 2008 Oct;26(7):741-6. doi: 10.1002/cbf.1465.

引用本文的文献

1
Reye Syndrome with Severe Hyperammonemia and a Good Neurological Outcome.
Am J Case Rep. 2021 Oct 11;22:e932864. doi: 10.12659/AJCR.932864.
2
[Reye syndrome and sudden death symptoms after oral administration of nimesulide due to upper respiratory tract infection in a boy].
Zhongguo Dang Dai Er Ke Za Zhi. 2018 Nov;20(11):944-949. doi: 10.7499/j.issn.1008-8830.2018.11.013.
3
Liver pathology in Malawian children with fatal encephalopathy.
Hum Pathol. 2011 Sep;42(9):1230-9. doi: 10.1016/j.humpath.2010.11.019. Epub 2011 Mar 10.
4
Aspirin and Reye syndrome.
Paediatr Drugs. 2007;9(3):205-6. doi: 10.2165/00148581-200709030-00009.
5
Aspirin and Reye syndrome: a review of the evidence.
Paediatr Drugs. 2007;9(3):195-204. doi: 10.2165/00148581-200709030-00008.
6
Reye's syndrome: the case for a causal link with aspirin.
Drug Saf. 2006;29(12):1111-21. doi: 10.2165/00002018-200629120-00003.
7
Surveillance for rare disorders by the BPSU. The British Paediatric Surveillance Unit.
Arch Dis Child. 2002 Oct;87(4):269-71. doi: 10.1136/adc.87.4.269.
8
Reye's syndrome revisited. Outdated concept of Reye's syndrome was used.
BMJ. 2002 Mar 2;324(7336):546. doi: 10.1136/bmj.324.7336.546.
9
Reye syndrome--insights on causation and prognosis.
Arch Dis Child. 2001 Nov;85(5):351-3. doi: 10.1136/adc.85.5.351.
10
Lesson of the week: Reye's syndrome and aspirin: lest we forget.
BMJ. 2001 Jun 30;322(7302):1591-2. doi: 10.1136/bmj.322.7302.1591.

本文引用的文献

1
Reye's syndrome 30 years on.
BMJ. 1993 Oct 16;307(6910):950-1. doi: 10.1136/bmj.307.6910.950.
2
Reye's syndrome.
BMJ. 1994 Apr 2;308(6933):919-20. doi: 10.1136/bmj.308.6933.919b.
3
Aspirin and Reye's syndrome.
Lancet. 1993 Apr 10;341(8850):968. doi: 10.1016/0140-6736(93)91266-o.
4
Reduction of deaths after drug labelling for risk of Reye's syndrome.
Lancet. 1993 Jan 9;341(8837):118-9. doi: 10.1016/0140-6736(93)92599-o.
5
Reye's syndrome and salicylate use.
Pediatrics. 1980 Dec;66(6):859-64.
6
Reye's syndrome and medication use.
JAMA. 1982 Aug 13;248(6):687-91.
7
Aspirin as a risk factor in Reye's syndrome.
JAMA. 1982 Jun 11;247(22):3089-94.
9
A comparison of liver ultrastructure in salicylate intoxication and Reye's syndrome.
Hepatology. 1984 Jul-Aug;4(4):687-90. doi: 10.1002/hep.1840040421.
10
Reye's syndrome: salicylates and mitochondrial functions.
Biochem Pharmacol. 1984 Sep 15;33(18):2869-76. doi: 10.1016/0006-2952(84)90209-0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验